Analytical Comparison Of MSC-EV Quality Attributes Across Tissue Sources And Production Platforms

Manufacturing scalable quantities of mesenchymal stem cell-derived extracellular vesicles for clinical applications demands clarity on which quality attributes remain consistent across production methods and which vary by donor or tissue source. Particle size, protein content, surface markers, microRNA cargo, and functional enzyme activity all represent critical parameters that could impact therapeutic efficacy.

Learn how comprehensive analytical characterization across bone marrow, umbilical cord, and adipose-derived MSCs reveals patterns in EV production across 3D bioreactor platforms and traditional 2D systems. While particle concentration and size distribution remained platform-independent for a given tissue source, significant differences emerged in particle dimensions across tissue types and in both particle yield and CD73 enzymatic activity across individual donors.

Access the poster below to understand which variables require standardization in your manufacturing process and which quality attributes demand donor screening protocols for consistent therapeutic outcomes.